Insurers paying higher prices for drugs at top-performing hospitals
The once-confidential prices have come to light thanks to the federal price transparency rule.
By Alan Goforth|November 12, 2021 at 09:57 AM
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
Reimbursement for clinician-administered drugs under Medicare Part B is set at the average sales price charged by manufacturers to wholesalers, plus a 6% markup. Although these prices had long been confidential, hospitals now are required to post payer-specific negotiated prices under a transparency rule that took effect early this year.
In a report published in JAMA Internal Medicine, researchers analyzed a set of top-performing hospitals to quantify drug pricing variation across insurers Among their findings:
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
61% of employers surveyed consider caregiving benefits to be a top priority for their business and employees, yet 22% consider themselves as below average in developing caregiving benefits. Download this info sheet to help your clients remain competitive by offering a care benefit package.